BR100 Increased By (2.89%)
BR30 Increased By (3.65%)
KSE100 Increased By (2.38%)
KSE30 Increased By (2.44%)
AGHA 6.13 Increased By ▲ 0.10 (1.66%)
BECO 4.18 Increased By ▲ 0.32 (8.29%)
BML 61.62 Increased By ▲ 0.62 (1.02%)
BOP 30.90 Increased By ▲ 2.81 (10%)
CNERGY 12.03 Increased By ▲ 0.29 (2.47%)
CSIL 5.47 Increased By ▲ 0.17 (3.21%)
FCCL 56.90 Increased By ▲ 2.44 (4.48%)
FFL 13.35 Increased By ▲ 0.28 (2.14%)
FNEL 1.16 Increased By ▲ 0.05 (4.5%)
KEL 5.98 Increased By ▲ 0.35 (6.22%)
KOSM 5.49 Increased By ▲ 0.15 (2.81%)
LOTCHEM 24.43 Increased By ▲ 0.60 (2.52%)
MLCF 97.90 Increased By ▲ 4.92 (5.29%)
NBP 173.82 Increased By ▲ 10.62 (6.51%)
NCPL 48.55 Increased By ▲ 0.28 (0.58%)
NPL 50.15 Increased By ▲ 0.44 (0.89%)
OGDC 311.00 Increased By ▲ 7.37 (2.43%)
PACE 9.08 Increased By ▲ 0.11 (1.23%)
PAEL 33.16 Increased By ▲ 1.25 (3.92%)
PIBTL 13.18 Increased By ▲ 0.44 (3.45%)
PPL 217.77 Increased By ▲ 4.86 (2.28%)
PRL 85.67 Increased By ▲ 1.33 (1.58%)
PTC 46.29 Increased By ▲ 1.30 (2.89%)
SSGC 23.30 Increased By ▲ 0.47 (2.06%)
TBL 9.00 Increased By ▲ 0.12 (1.35%)
TELE 6.71 Increased By ▲ 0.21 (3.23%)
TPL 25.90 Increased By ▲ 1.64 (6.76%)
TPLP 12.70 Increased By ▲ 0.71 (5.92%)
TREET 23.79 Increased By ▲ 0.65 (2.81%)
TRG 53.00 Increased By ▲ 1.53 (2.97%)
World

England to start using Moderna jab on Tuesday

  • Health officials started using the Moderna jab in Wales last week and had said it would be rolled out across the rest of the United Kingdom in the coming days.
Published Updated
By

LONDON: England will start using the Moderna vaccine on Tuesday, which will be used at over 20 sites this week as the third shot that is available in Britain for COVID-19.

Health officials started using the Moderna jab in Wales last week and had said it would be rolled out across the rest of the United Kingdom in the coming days.

"More than 20 sites, including Reading's Madejski Stadium and the Sheffield Arena, will initially use the newest vaccine, as the NHS continues to expand the vaccination programme," the health service said in a statement.

Comments

Comments are closed for this article.